Marinomed Biotech AG

Major Shareholding Notification • Jan 27, 2020

Publication Date: 27.01.2020 14:00 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Overview 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Acquisition or disposal of voting rights 3. Person subject to notification obligation Acting in concert (Sec. 133 No. 7 BörseG 2018)

First name	________________ Name/Surname	City	Country
Abdulmohsen	__ ___ ___ _____ Al Sheikh
Mohammed	__ ___ ___ _____ Al Sheikh
	__ ___ ___ _____ Acropora Beteiligungs GmbH	Vienna	Austria

1. Name of shareholder(s):

2. Date on which the threshold was crossed or reached: 22.1.2020

3. Total positions:

				____________
		% of voting
		rights through
	% of voting			financial/other Total of both Total number of
	rights attached instruments		in % (7.A +	voting rights of
	to shares (7.A) (7.B.1 + 7.B.2) 7.B)			issuer
				__ __ ___ ___ __
Resulting
situation on
the date on
which threshold	16.59 %	0,00 %	16.59 %	1,469,772
was crossed /
reached
				__ __ ___ ___ __
Position of
previous
notification	23.27 %	0,00 %	23.27 %
(if applicable)
				__ __ ___ ___ __

Details

1. Notified details of the resulting situation:

|A: Voting rights attached to shares |

	Number of voting rights	____________ % of voting rights ____ ______
	Direct	Indirect (Sec		Direct	Indirect (Sec
ISIN Code	(Sec 130 BörseG 133 BörseG 2018)	2018)		(Sec 130 BörseG 133 BörseG 2018)	2018)
	__ ___ ___ __ ____

______________________________________________________________________________

AT0000831706	243,860		16.59 %
SUBTOTAL A		243,860		__ ___ ___ __ ____ 16.59%
				__ _____ _________

BörseG 2018	______________ B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1
Type of	______________ instrument Expiration Date	Exercise Period the instrument is rights		Number of voting rights that may be acquired if		% of voting
	_ __ __ __ _ _ __ __ __ _ ____ __ __ _	SUBTOTAL B.1		exercised

__________ B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018 __________
Type of	Date	Period	Expiration Exercise Physical / Cash Number of Settlement	voting rights rights	% of voting
			instrument _ _ ___ __ _ _ _ _ ___ ___ ___
			SUBTOTAL B.2 ____ __ ____ _____

1. Information in relation to the person subject to the notification obligation: Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

				___________
		Directly		Financial/ other
			controlled Shares held instruments		Total of both
No.	Name	by No.		directly (%) held directly	(%)
				(%)
				_ ___ __ _ _ ____
	Abdulmohsen
1	Al Sheikh
				_ ___ __ _ _ ____
	Mohammed Al
2	Sheikh			_ ___ __ _ _ ____
	Acropora
3	Beteiligungs	1,2	16.59 %		16.59 %
	GmbH
				_ ___ __ _ _ ____

1. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights. 10. Additional comments: The disclosure obligation arose because the number of shares held dropped below the threshold due to the sale of 73,500 shares.

---

Further inquiry note: Dr. Eva Prieschl-Grassauer Chief Scientific Officer, Marinomed Veterinärplatz 1, 1210 Vienna, Austria T +43 (0)1 250 77 4460 E-Mail: eva.prieschl@marinomed.com http://www.marinomed.com

Roland Mayrl Managing Partner, Metrum Communications Bauernmarkt 10/19, 1010 Vienna, Austria T +43 (0) 1 504 69 87 331 E-Mail: r.mayrl@metrum.at http://www.metrum.at

end of announcement euro adhoc

Marinomed Biotech AG
Veterinärplatz 1
A-1210 Wien
0043250774460
0043250774493
office@marinomed.com
www.marinomed.com
ATMARINOMED6, AT0000A1WD52
stockmarkets: Wien
English

Aussendung übermittelt durch euro adhoc The European Investor Relations Service